NCT04518098

Brief Summary

Falls are a major health concern amongst older adults with cancer, and are often related to decreased physical strength due to effects of cancer and its treatments. Ample evidence demonstrates the benefits of exercise programs incorporating strength and balance training on lower body strength, balance, and fall prevention older adults. However, gaps in research exist within the geriatric oncology context. The purpose of this study is to determine the feasibility and efficacy of a 3-month, remotely delivered exercise program regimen on lower body strength, balance, and falls in older adults with cancer. This observer-blinded, randomized controlled feasibility trial aims to recruit older cancer patients (aged ≥65). Participants in the intervention group will undertake the exercise program 3 times weekly for three months. Data collection will include sociodemographic survey, baseline, end-of-intervention (3-month) assessment, follow-up (6-month) assessment, chart review, and exit survey. Descriptive and inferential statistics will be used to analyze data, following the intention-to-treatment principle. Data generated from this research project will inform design of a subsequent, larger exercise intervention trial. This is an important step to establish the knowledge base regarding provision of exercise interventions as a fall prevention strategy to reduce falls and their negative outcomes in older patients in the community.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
74

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 18, 2019

Completed
1.1 years until next milestone

First Posted

Study publicly available on registry

August 19, 2020

Completed
2.4 years until next milestone

Study Start

First participant enrolled

January 1, 2023

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2023

Completed
Last Updated

May 10, 2023

Status Verified

May 1, 2023

Enrollment Period

9 months

First QC Date

July 18, 2019

Last Update Submit

May 8, 2023

Conditions

Keywords

resistance and balance trainingfall preventionolder adultscancerExercise

Outcome Measures

Primary Outcomes (3)

  • 30-second Chair Stand test

    The 30-second chair stand test will begin with having the participating sitting upright in the middle of the chair with arms folded across the chest with hands placed on the front of the opposite shoulder. The feet are placed flat on the ground at shoulder width and slightly behind the knee. At the initiation of the test using a count down of "ready…go," the participant will stand upright (knees straight and torso fully erect) while maintaining the hand position on the shoulder and then return to a fully seated position in which body weight is shifted from the feet to the chair. The participant will complete as many stand-sit cycles as possible in the 30-second period. The number of sit-to-stands completed within the 30 seconds will be recorded and interpreted based on age group and gender as recommended by the Centers for Disease Control and Prevention STEADI guideline.

    Baseline, 3 & 6 months - to measure change

  • Balance test

    Static balance ability will be measured using the Side-by-side Stand (SBS), Semi-tandem Stand (ST), and Full tandem Stand (FT). Participants will be asked to maintain their balance in the three different positions. The amount of time they succeed in maintaining the various positions, in seconds, will be recorded based on the following criteria: Side-by-side 10 sec, semi-tandem 10 sec (1 point); tandem 10 sec (2 points), tandem 3-9.99 second (1 point).

    Baseline, 3 & 6 months - to measure change

  • Fall assessment

    Falls will be assessed at t0, t1, and t2 as described, by self-report following recommendations of fall assessment as outlined by the American Geriatrics Society/British Geriatrics Society (AGS/BGS)

    Baseline, 3 & 6 months - to measure change

Study Arms (2)

Intervention group

EXPERIMENTAL

Participants in the IG will receive the STABLE intervention, which entails orientation, and undertaking a remotely delivered resistance and balance training regimen 3 times weekly for 3 months

Other: Strength and balance exercise

Control group

NO INTERVENTION

Participants in the CG will not receive the intervention, and will be advised to carry out their usual daily activities.

Interventions

The exercise program consists of muscle strengthening and balance training exercises that progress in difficulty. After completion of the baseline assessment and randomization, IG participants will receive orientation and learn the exercise routines (in the Cancer Rehabilitation Clinic within the Faculty of Rehabilitation Medicine at the University of Alberta). The duration of training is 3 months (40-50 minutes per scheduled session, three times a week) at home, with a minimum of one live group session supervised by the CEP, a minimum of one independent home session supported by the Active Living module of the HEAL-ME application; (the third session can be a live session or independent session at the participant's discretion).

Intervention group

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Adults aged 65 or above;
  • living in the community;
  • have a confirmed diagnosis of any stage of lung, breast, prostate, or colorectal cancer; - currently receiving, starting or have completed systemic anti-cancer therapy;
  • life-expectancy of at least 9 months (in consideration of the measurement period of the study and also avoid burdening patients who are near the end-stage of their disease); and - completed the PAR-Q screening or have approval of their treating physician.

You may not qualify if:

  • presence of brain metastases;
  • presence of unstable metastases as per treating physician (e.g., bone metastasis in a weight-bearing area, recent bone fracture);
  • presence of any conditions that would potentially interfere with their ability to carry out the exercise interventions (e.g., mobility impairment, poorly controlled pain, severe vision/hearing loss, severe arthritis that limits ambulation, left-sided heart failure, neurological or musculoskeletal conditions);
  • self-reported history of light-headedness during physical activities; syncopal episodes within the past month; and
  • participation in any form of structured exercise program (that are at least 30 minutes per week) at the time of consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cross Cancer Institute

Edmonton, Saskatchewan, Canada

RECRUITING

Related Publications (1)

  • Sattar S, Haase KR, Alibhai SMH, Penz K, Szafron M, Harenberg S, Amir E, Kuster S, Pitters E, Campbell D, McNeely ML. Feasibility and efficacy of a remotely delivered fall prevention exercise program for community-dwelling older adults with cancer: Protocol for the STABLE trial. J Geriatr Oncol. 2022 Nov;13(8):1273-1280. doi: 10.1016/j.jgo.2022.06.009. Epub 2022 Jul 2.

MeSH Terms

Conditions

NeoplasmsMotor Activity

Condition Hierarchy (Ancestors)

Behavior

Study Officials

  • Schroder Sattar, RN, PhD

    College of Nursing

    PRINCIPAL INVESTIGATOR
  • Margaret McNeely, PhD

    University of Alberta

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Schroder Sattar, RN, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Assessors who collect outcome data will be blinded to group allocation. Participants will be advised to refrain from disclosing their group allocation to the outcome assessor.
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

July 18, 2019

First Posted

August 19, 2020

Study Start

January 1, 2023

Primary Completion

September 30, 2023

Study Completion

November 30, 2023

Last Updated

May 10, 2023

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will not share

Locations